To observe the changes of plasma microRNA levels and its clinical significance in pediatric liver transplantation patients

miRNA29a is involved in the mechanism of myocardial injury in pediatric liver transplantation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200056664

Enrollment

Unknown

Registered

2022-02-10

Start date

2022-02-05

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary atresia

Interventions

one:no

Eligibility

Sex/Gender

All

Age

No minimum to 2 Years

Inclusion criteria

Inclusion criteria: 1. Children diagnosed as biliary atresia; 2. Age: 5 months to 2 years old; 3. The anesthesia grade (ASA grade) is II to III; 4. Cardiac function grading is grade I to II.

Exclusion criteria

Exclusion criteria: 1. No coexisting diseases such as heart, lung, brain and kidney before operation; 2. Second liver transplantation.

Design outcomes

Primary

Measure	Time frame
hs-cTn I;miRNA29a;LDH;CK-MB;NT-proBNP;	—

Countries

China

Contacts

Public ContactWeng Yiqi

Tianjin First Center Hospital

wyqhyd@126.com+86 18698017513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026